Silence Therapeutics (SLN) Other Working Capital Changes (2020 - 2026)
Silence Therapeutics recorded quarterly Other Working Capital Changes of -$24000.0 in Q1 2026, down 9.09% quarter-over-quarter from -$22000.0 in Q4 2025, and down 104.05% year-over-year from $592000.0 in Q1 2025.
Silence Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$24000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 104.05% year-over-year to -$24000.0; the TTM figure through Mar 2026 stood at -$784000.0 (up 97.56% YoY), while the FY2025 annual figure was $110379.0, down 75.9% from the prior year.
- Other Working Capital Changes came in at -$24000.0 for Q1 2026 at Silence Therapeutics, down from -$22000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.7 million in Q4 2023 to a low of -$30.5 million in Q4 2024.
- A 5-year average of -$2.2 million and a median of -$22000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes sank 1223.42% in 2024 and jumped 524.48% in 2025, its largest moves.
- Silence Therapeutics' Other Working Capital Changes stood at $701411.1 in 2022, then jumped by 287.17% to $2.7 million in 2023, then tumbled by 1223.42% to -$30.5 million in 2024, then jumped by 99.93% to -$22000.0 in 2025, then slipped by 9.09% to -$24000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$24000.0, -$22000.0, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24,000.00 |
| Mar 31, 2026 | -24,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | 2.28 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Mar 31, 2025 | 592,000.00 |
| Mar 31, 2025 | 592,000.00 |
| Dec 31, 2024 | -30.51 Mn |
| Dec 31, 2024 | -30.51 Mn |
| Sep 30, 2024 | 365,103.35 |
| Sep 30, 2024 | 365,103.35 |
| Jun 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | -2.64 Mn |
| Mar 31, 2024 | 768,000.00 |
| Mar 31, 2024 | 768,000.00 |
| Dec 31, 2023 | 2.72 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 701,411.14 |
| Dec 31, 2022 | 701,411.14 |
| Sep 30, 2022 | -2.39 Mn |
| Sep 30, 2022 | -2.39 Mn |
| Jun 30, 2022 | -2.66 Mn |
| Jun 30, 2022 | -2.66 Mn |
| Mar 31, 2022 | -920,499.29 |
| Mar 31, 2022 | -920,499.29 |
| Dec 31, 2021 | -3.56 Mn |
| Dec 31, 2021 | -3.56 Mn |
| Sep 30, 2021 | 996,715.76 |
| Sep 30, 2021 | 996,715.76 |
| Jun 30, 2021 | 392,761.64 |
| Jun 30, 2021 | 392,761.64 |
| Mar 31, 2021 | 1.01 Mn |
| Mar 31, 2021 | 1.01 Mn |
| Dec 31, 2020 | -1.86 Mn |
| Dec 31, 2020 | -1.86 Mn |
| Sep 30, 2020 | -67.20 Mn |
| Sep 30, 2020 | -67.20 Mn |